Arcturus Therapeutics Holdings Inc (ARCT)

$27.24 0.32 (1.19%)

16:00 EDT ARCT Stock Quote Delayed 30 Minutes

3 Biotech Stocks to Buy Before the Breakout

By Michael Que, InvestorPlace Contributor Jul 28, 2023

Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.

3 Biotech Stocks for Getting Rich in 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?

Volume:

Previous Close -

Market Cap 723.57M

PE Ratio 5.47

EPS 4.98

Volume (Avg. Vol.) 336,287

Day's Range $26.62 - $27.70

52-Week Range $13.02 - $37.75

Dividend & Yield N/A (N/A)

ARCT Stock Predictions, Articles, and Arcturus Therapeutics Holdings Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 2, 2022

Good morning, trader! It's time to take a look at all of the latest news behind the biggest pre-market stock movers on Thursday!

7 Small-Cap Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later

By Josh Enomoto, InvestorPlace Contributor Sep 22, 2022

With the market taking a dip and possibly poised to incur more red ink, these are the small-cap stocks to buy that appeal to contrarians.

7 Busted Biotech Stocks Due for a Rebound

By Chris Lau, InvestorPlace Contributor Sep 8, 2021

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally.

7 Best Vaccine Stocks for Their Pipeline Potential

By Faisal Humayun, InvestorPlace Contributor Jun 3, 2021

These Covid-19 vaccine stocks may be late in the race, but they certainly have growth potential as we head into the summer.

Be Careful with Novavax and the Recent Surge in NVAX Stock

By Luke Lango, InvestorPlace Senior Investment Analyst Jun 29, 2020

Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.

7 Red-Hot Vaccine Stocks Racing to Develop a Coronavirus Cure

By Luke Lango, InvestorPlace Senior Investment Analyst May 28, 2020

A race to develop a coronavirus vaccine is on, and these red-hot Covid-19 vaccine stocks are leading the way.

7 “Perfect 10” Healthcare Stocks to Buy Now

By Maya Sasson, Writer, TipRanks Mar 18, 2020

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

Arcturus, CSL granted EU review for COVID shot (NASDAQ:ARCT)

From Seeking Alpha Sep 5, 2023

Arcturus Therapeutics (ARCT) and CSL Limited (CSLLY) announced Tuesday that the EU accepted the marketing application for their COVID vaccine, ARCT-154. Read more here.

Arcturus Therapeutics' joint venture, ARCALIS $115M Japanese government (NASDAQ:ARCT)

From Seeking Alpha Aug 14, 2023

Arcturus Therapeutics (ARCT) said that ARCALIS, its manufacturing joint venture in Japan to support the production of mRNA vaccines and therapeutics, has been awarded $115M in two...

Why Shares of Arcturus Therapeutics Dropped on Tuesday

From The Motley Fool Aug 8, 2023

The company saw revenue decline and net losses rise in the second quarter.

Arcturus down 18% on disappointing Q2 results (NASDAQ:ARCT)

From Seeking Alpha Aug 8, 2023

Arcturus Therapeutics (ARCT) is down ~18% following Q2 2023 financial results released after the closing bell Aug. 7. Read more here.

Arcturus Therapeutics receives FDA fast track status for ARCT-810 (ARCT)

From Seeking Alpha Jun 1, 2023

Arcturus Therapeutics (ARCT) drug candidate ARCT-810 has received fast track designation from the US Food and Drug Administration in the treatment of genetic liver disease OTC.

Why Arcturus Therapeutics Stock Is Soaring Today

From The Motley Fool Mar 29, 2023

Investors liked what they heard in its Q4 update.

Arcturus Therapeutics Holdings Inc (ARCT)

3 Biotech Stocks to Buy Before the Breakout

3 Biotech Stocks for Getting Rich in 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Arcturus Therapeutics Holdings Inc (ARCT)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ARCT Stock Predictions, Articles, and Arcturus Therapeutics Holdings Inc News

Subscriber Sign in